AFT Pharmaceuticals outlines shareholder value focus in 2025 AGM
At its annual shareholders meeting in Auckland today, AFT Pharmaceuticals (ASX:AFP) laid out its plans to leverage the company’s R@D pipeline as it hunts out new addressable markets worth as much as US$8 billion.Listen to the HotCopper podcast for in-depth discussions and insights...
The Watchlist
Previous Video
Next Video
RC1
REDCASTLE RESOURCES LIMITED
Ron Miller, Non-Executive Director
Ron Miller
Non-Executive Director
Previous Video
Next Video
SPONSORED BY The Market Online